Scarlet fever changes its spots - 24/10/19
Doi : 10.1016/S1473-3099(19)30494-3
Stephan Brouwer a, Jake A Lacey b, Yuanhai You c, Mark R Davies b, Mark J Walker a 
a School of Chemistry and Molecular Biosciences and Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD 4072, Australia
b Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia
c State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Il testo completo di questo articolo è disponibile in PDF.
© 2019
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 19 - N° 11
P. 1154-1155 - novembre 2019 Ritorno al numero
Articolo precedente
- Increased mortality in survivors of Ebola virus disease
- Hugues Fausther-Bovendo, Gary Kobinger
- Essential metrics for high-quality reporting of neonatal sepsis research in low-resource settings
- Helena Rabie, Mark Cotton, Angela Dramowski
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?